🇺🇸 FDA
Patent

US 10898497

Compositions and methods for cartilage repair

granted A61KA61K31/19A61K31/375

Quick answer

US patent 10898497 (Compositions and methods for cartilage repair) held by Regenexx, LLC expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regenexx, LLC
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/19, A61K31/375, A61K31/56, A61K31/573